U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
162151162151Everolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous TreatmentCompletedHas ResultsLeukemia|Lymphoma|Lymphoproliferative DisorderDrug: Everolimushttps://ClinicalTrials.gov/show/NCT00436618
162152162152Dasatinib in Treating Patients With Stage III Melanoma That Cannot Be Removed By Surgery or Stage IV MelanomaCompletedHas ResultsRecurrent Melanoma|Stage IIIA Melanoma|Stage IIIB Melanoma|Stage IIIC Melanoma|Stage IV MelanomaDrug: dasatinibhttps://ClinicalTrials.gov/show/NCT00436605
162153162153Safety and Efficacy of NeuroFlo in 8-24 Hour Stroke PatientsCompletedNo Results AvailableCerebrovascular AccidentDevice: NeuroFloâ„¢ Catheterhttps://ClinicalTrials.gov/show/NCT00436592
162154162154Sorafenib in Treating Patients With Advanced Solid TumorsTerminatedNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificDrug: sorafenib tosylate|Other: pharmacological study|Procedure: assessment of therapy complications|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00436579
162155162155Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By SurgeryCompletedHas ResultsBreast Cancer|Cardiac ToxicityBiological: trastuzumab|Drug: cyclophosphamide|Drug: doxorubicin hydrochloride|Drug: lapatinib ditosylate|Drug: paclitaxel|Genetic: gene expression analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: fluorophotometry|Other: laboratory biomarker analysis|Other: mass spectrometry|Procedure: adjuvant therapy|Procedure: quality-of-life assessmenthttps://ClinicalTrials.gov/show/NCT00436566
162156162156Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal NeovascularizationCompletedHas ResultsMacular Degeneration|Choroidal NeovascularizationDrug: Verteporfin Photodynamic Therapy|Drug: Ranibizumab|Drug: Verteporfin Placebo|Drug: Ranibizumab Placebohttps://ClinicalTrials.gov/show/NCT00436553
162157162157A Comparison Between Clobetasol Propionate 0.05% (Clobex®) Spray and Clobetasol Propionate 0.05% (Olux®) FoamCompletedNo Results AvailablePsoriasisDrug: Clobetasol Propionate 0.05% Spray|Drug: Clobetasol Propionate 0.05% Foamhttps://ClinicalTrials.gov/show/NCT00436540
162158162158Assess the Ability of MetroGel 1% to Deliver Moisture to Facial Skin After a Single ApplicationCompletedNo Results AvailableRosaceaDrug: Metronidazole gel 1%https://ClinicalTrials.gov/show/NCT00436527
162159162159Colonoscopy by Videocapsuls Versus Standard Colonoscopy. Intra-individual Comparison for the Subject With a Medium or High Risk of Colorectal Cancer.CompletedNo Results AvailableColorectal CancerBehavioral: diet and absorption of ColoPEG|Procedure: Colonoscopy with colic videocapsule|Procedure: Standard colonoscopyhttps://ClinicalTrials.gov/show/NCT00436514
162160162160VEGF Trap and Docetaxel in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube CancerCompletedHas ResultsFallopian Tube Cancer|Malignant Tumor of Peritoneum|Recurrent Ovarian Epithelial CancerDrug: docetaxel|Biological: ziv-aflibercept|Other: laboratory biomarker analysis|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT00436501
162161162161Frequency of ICAM-1 Polymorphisms in Obese SubjectsCompletedNo Results AvailableObesityhttps://ClinicalTrials.gov/show/NCT00436488
162162162162Vitamin D and Calcium Homeostasis for Prevention of Type 2 DiabetesCompletedNo Results AvailableGlucose Intolerance|Type 2 Diabetes Mellitus|Metabolic SyndromeDrug: Vitamin D3 2,000 IU orally once daily|Drug: Calcium Carbonate 400 mg orally twice daily|Drug: Vitamin D3-Placebo|Drug: Calcium-Placebohttps://ClinicalTrials.gov/show/NCT00436475
162163162163Expression of Steroid Receptors in EndometriumCompletedNo Results AvailableEndometriumhttps://ClinicalTrials.gov/show/NCT00436462
162164162164RN1001(Avotermin) in Scar Improvement Following Breast AugmentationCompletedNo Results AvailableMammaplasty|CicatrixDrug: Avoterminhttps://ClinicalTrials.gov/show/NCT00436449
162165162165O(6)-Benzylguanine and Temozolomide in Treating Patients With Glioblastoma Multiforme That Did Not Respond to Previous Temozolomide and Radiation TherapyActive, not recruitingNo Results AvailableBrain and Central Nervous System TumorsDrug: O6-benzylguanine|Drug: temozolomidehttps://ClinicalTrials.gov/show/NCT00436436
162166162166A Phase â…¡ Study of Gemcitabine Combination With TS-1 in Patient With Advanced or Recurred Pancreatic CancerCompletedNo Results AvailablePancreatic Neoplasm|Neoplasm MetastasisDrug: gemcitabine, TS-1https://ClinicalTrials.gov/show/NCT00436423
162167162167Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic CancerCompletedNo Results AvailableAdrenocortical Carcinoma|Breast Cancer|Colorectal Cancer|Gastrointestinal Cancer|Kidney Cancer|Liver Cancer|Melanoma (Skin)|Ovarian Cancer|Pancreatic Cancer|SarcomaBiological: colloidal gold-bound tumor necrosis factor|Other: electron microscopy|Other: pharmacological study|Procedure: conventional surgeryhttps://ClinicalTrials.gov/show/NCT00436410
162168162168A New Radiation Therapy Planning System in Patients Undergoing Radiation Therapy for CancerCompletedNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificRadiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00436397
162169162169Cell Mediated Immunity and the Prediction of CMV Infection In Solid Organ Transplant RecipientsCompletedNo Results AvailableTransplantProcedure: Monitoring-blood samples drawn for CMV testinghttps://ClinicalTrials.gov/show/NCT00436384
162170162170Amisulpride in Schizophrenic Acute Phase PatientsCompletedNo Results AvailableSchizophreniaDrug: Amisulpridehttps://ClinicalTrials.gov/show/NCT00436371
162171162171Implementing Hospital-based Active Surveillance Procedures for Vaccine Safety Monitoring at IMSS Hospitals in MexicoCompletedNo Results AvailableIntussusception|LRTI-related Post Neonatal DeathsOther: Not applicable: nonehttps://ClinicalTrials.gov/show/NCT00436358
162172162172Pharmacoeconomic Consequences Of Analgesia in the Intensive Care Unit (ICU)TerminatedHas ResultsAnalgesiaDrug: Remifentanil|Drug: Propofolhttps://ClinicalTrials.gov/show/NCT00436345
162173162173S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar CarcinomaActive, not recruitingNo Results AvailableLung CancerBiological: bevacizumab|Drug: erlotinib hydrochloridehttps://ClinicalTrials.gov/show/NCT00436332
162174162174Duration of GnRH-analogue Downregulation and Pregnancy RatesTerminatedNo Results AvailableInfertilityProcedure: Duration of GnRH agonist downregulationhttps://ClinicalTrials.gov/show/NCT00436319
162175162175Stage Matched Intervention to Increase Dual Method UseCompletedNo Results AvailableContraception|Sexually Transmitted Diseases|PregnancyBehavioral: Individualized Interventionhttps://ClinicalTrials.gov/show/NCT00436306
162176162176Taxotere + Cisplatin in Nasopharyngeal CarcinomaCompletedNo Results AvailableNasopharyngeal NeoplasmsDrug: Docetaxel|Drug: Cisplatinhttps://ClinicalTrials.gov/show/NCT00436293
162177162177Chemotherapy for Patients With LymphomaCompletedNo Results AvailableLymphoma, Large Cell, DiffuseDrug: enzastaurin|Drug: gemcitabine|Drug: rituximab|Drug: oxaliplatinhttps://ClinicalTrials.gov/show/NCT00436280
162178162178Internal Radiation Therapy With Y-90 Microspheres, External Radiation Therapy With Tomotherapy, and Fluorouracil in Treating Patients With Newly Diagnosed or Recurrent Pancreatic Cancer and Liver Metastases That Cannot Be Removed By SurgeryActive, not recruitingNo Results AvailableMetastatic Cancer|Pancreatic CancerDrug: fluorouracil|Radiation: selective external radiation therapy|Radiation: tomotherapy|Radiation: yttrium Y 90 glass microspheres|Radiation: yttrium Y 90 resin microsphereshttps://ClinicalTrials.gov/show/NCT00436267
162179162179Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian CancerActive, not recruitingNo Results AvailableHER2-positive Breast Cancer|Stage III Ovarian Epithelial Cancer|Stage III Ovarian Germ Cell Tumor|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer|Stage IV Ovarian Epithelial Cancer|Stage IV Ovarian Germ CeBiological: pNGVL3-hICD vaccine|Biological: sargramostim|Other: flow cytometry|Other: immunologic technique|Other: immunoenzyme technique|Genetic: protein expression analysis|Procedure: biopsyhttps://ClinicalTrials.gov/show/NCT00436254
162180162180A Study of Xeloda (Capecitabine) as First-Line Chemotherapy in Patients With Advanced or Metastatic Gastric Cancer.CompletedNo Results AvailableGastric CancerDrug: Oxaliplatin|Drug: capecitabine [Xeloda]https://ClinicalTrials.gov/show/NCT00436241

* Görseller ve İçerik tekif hakkına sahip olabilir